FY22-DBH- Naloxone HCL 4MG Nasal Spray

Closed State & local contract opportunity Posted

Solicitation number
Doc606612
State
District of Columbia
Responses due

Opportunity facts

NIGP code

Opportunity details come from contracts.ocp.dc.gov. Updated .

About this opportunity

The District of Columbia's Department of Behavioral Health (DBH) is seeking to procure Naloxone HCL 4MG Nasal Spray through a competitive solicitation process for fiscal year 2022. This procurement opportunity focuses on acquiring a critical medication used for emergency opioid overdose reversal, specifically targeting nasal spray formulations at a 4MG concentration. The contract aims to supply naloxone for public health and emergency response purposes, with a clear objective of supporting overdose prevention and treatment efforts within the District. The solicitation was posted on March 10, 2022, with a proposal submission deadline of March 25, 2022, providing potential vendors approximately 15 days to prepare and submit their responses. While specific evaluation criteria are not explicitly detailed in the provided information, typical procurement processes for medical supplies involve assessments of product quality, pricing, vendor capabilities, delivery timelines, and compliance with technical specifications.

The contract opportunity does not specify explicit set-aside designations or minority enterprise restrictions based on the available information. However, government procurement typically encourages participation from small businesses, disadvantaged business enterprises, and local vendors when possible. No incumbent vendors or current contractors are identified in the document. The procurement appears focused on a specific medical supply with potential implications for public health emergency preparedness. While precise budget ranges are not disclosed, medical supply contracts for municipal governments often involve substantial annual allocations, particularly for critical overdose intervention medications. Vendors responding to this solicitation should be prepared to demonstrate their ability to consistently supply high-quality naloxone nasal spray, meet stringent medical product standards, and potentially provide supporting documentation of manufacturing capabilities, product certifications, and distribution logistics.

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Similar opportunities
  • Ask GovTribe AI about this opportunity

GovTribe for State & Local Contractors